Mozilla has unveiled plans to help with the construction of smartphones costing as little as $25 (£15) as it looks to offer an alternative to Android, iOS and Windows Phone devices in emerging markets.
Mozilla, better known for its Firefox browser, has been entering the smartphone market in emerging nations for some time and to continue this growth has now partnered with two Indian firms to build super-cheap devices.
Indian companies Intex and Spice will manufacture the handsets running Firefox OS and use a low-cost processor from Chinese company Spreadtrum. They plan to have the new smartphones on sale in the next few months.
Sanjay Kalirona, business head for mobile at Intex, said the deal would help buyers in the country upgrade from basic feature phones to true web-enabled smartphones.
"This will propel our devices to be much more than a way to use the web, but take the engagement further and develop the web as a mobile platform," he said.
Mozilla chief operating officer Li Gong echoed this sentiment, saying that the deals and new devices would put the "power of the web" in the hands of millions more people around the world.
"Firefox OS frees consumers, developers, mobile providers and manufacturers from the limitations and restrictions of proprietary platforms," he wrote in a blog post.
Speaking to The Wall Street Journal, Gong added that this could take prices as low as $25 for a smartphone, effectively removing any price difference with feature phones.
"With a $25 price tag, there is no price gap between a smartphone and a feature phone," he told the paper. "This attractive price point would help motivate feature phone users to switch to smartphones."
Mozilla also announced new devices from partners ZTE and Alcatel already in the works that will go on sale in Latin America in the coming months running Firefox. These are the ZTE Open II and Alcatel OneTouch Fire E.
Facebook database included text-message metadata - despite not using Facebook Messenger for SMS
Successful attack could result in harm to patients and financial loss, warns NHS governing body